GROWTHFund research, explained
Indices › NIFTY Pharma TRI

NIFTY Pharma TRI

Shown through Nippon India Nifty Pharma ETF - Direct Plan, the lowest-cost fund tracking this index, until the official NSE TRI file is imported. Figures run slightly below the index by the fund's costs.
Level
29.17
19 Nov 2026
1 year
+25.28%
3 years (CAGR)
+21.97%
5 years (CAGR)
+16.60%
10 years (CAGR)
—

Growth of ₹100 since 6 Jul 2021

Calendar years

Risk

Volatility i
14.96%
Sharpe i
1.03
Deepest fall i
−20.98%
Oct 2021 → Mar 2023
Below its high i
−1.80%
Worst 1-year i
−15.30%
Middle 1-year
+13.45%
1-year periods with a loss i
26%
5-year SIP XIRR i
+20.60%

Funds that track it

Fund1Y3YTracking error
Nippon India Nifty Pharma ETF
Nippon India · Equity ETFs
+25.28%+21.97%0.00%
ICICI Prudential Nifty Pharma Index Fund
ICICI Pru · Index Funds (Equity)
+24.97%+21.56%0.11%
ICICI Prudential Nifty Pharma Index Fund
ICICI Pru · Index Funds (Equity)
+24.16%+20.81%0.12%
ICICI Prudential Nifty Pharma ETF
ICICI Pru · Equity ETFs
———

Lower tracking error = closer copy of the index.

Search Growth